Thomas T. Warner

Measuring clinical change in cervical dystonia: A comparison of the CDIP-58 with existing rating scales

Aj Thompson, Kailash P. Bhatia, Sj Cano, 2005 .

Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial

Andrew J. Lees, Thomas Foltynie, Patricia Limousin, 2018 .

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

Janice L. Holton, Andrew J. Lees, Thomas T. Warner, 2019, JAMA neurology.

A prevalence study of primary dystonia in eight European countries

E. Cassetta, Alfredo Berardelli, Joaquim J. Ferreira, 2000, Journal of Neurology.

A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells

Amit C. Nathwani, Cecilia Rosales, Thomas T. Warner, 2013, PloS one.

Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity

Sarah J. Tabrizi, Jan-Willem Taanman, Thomas T. Warner, 2000 .